Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2011

Open Access 01-06-2011 | Research article

Oestrogen deficiency modulates particle-induced osteolysis

Authors: Christophe Nich, Jean Langlois, Arnaud Marchadier, Catherine Vidal, Martine Cohen-Solal, Hervé Petite, Moussa Hamadouche

Published in: Arthritis Research & Therapy | Issue 3/2011

Login to get access

Abstract

Introduction

Postmenopausal osteoporosis may modulate bone response to wear debris. In this article, we evaluate the influence of oestrogen deficiency on experimental particle-induced osteolysis.

Methods

Polyethylene (PE) particles were implanted onto the calvaria of normal controls, sham-ovariectomized (OVX), OVX mice and OVX mice supplemented with oestrogen (OVX+E). After 14 days, seven skulls per group were analyzed using a high-resolution micro-computed tomography (micro-CT) and histomorphometry, and for tartrate-specific alkaline phosphatase. Five calvariae per group were cultured for the assay of IL-1β, IL-6, TNF-α and receptor activator of the nuclear factor κB (RANKL) secretion using quantitative ELISA. Serum IL-6 concentrations were obtained. The expression of RANKL and osteoprotegerin (OPG) mRNA were evaluated using real-time PCR.

Results

As assessed by μCT and by histomorphometry, PE particles induced extensive bone resorption and an intense inflammatory reaction in normal controls, sham-OVX and OVX+E mice, but not in the OVX mice group. In normal controls, sham-OVX and OVX+E mice, PE particles induced an increase in serum IL-6, in TNF-α and RANKL local concentrations, and resulted in a significant increase in RANKL/OPG messenger RNA (mRNA) ratio. Conversely, these parameters remained unchanged in OVX mice after PE implantation.

Conclusions

Oestrogen privation in the osteolysis murine model ultimately attenuated osteolytic response to PE particles, suggesting a protective effect. This paradoxical phenomenon was associated with a down-regulation of pro-resorptive cytokines. It is hypothesized that excessive inflammatory response was controlled, illustrated by the absence of increase of serum IL-6 in OVX mice after PE implantation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Willert HG, Bertram H, Buchhorn GH: Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res. 1990, 258: 95-107. Willert HG, Bertram H, Buchhorn GH: Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop Relat Res. 1990, 258: 95-107.
2.
go back to reference Schwarz EM, O'Keefe RJ, Looney RJ: Bone implant interface, osteolysis and potential therapies. J Musculoskelet Neuronal Interact. 2004, 4: 390-392. Schwarz EM, O'Keefe RJ, Looney RJ: Bone implant interface, osteolysis and potential therapies. J Musculoskelet Neuronal Interact. 2004, 4: 390-392.
3.
go back to reference Kobayashi S, Takaoka K, Saito N, Hisa K: Factors affecting aseptic failure of fixation after primary Charnley total hip arthroplasty. Multivariate survival analysis. J Bone Joint Surg Am. 1997, 79: 1618-1627. Kobayashi S, Takaoka K, Saito N, Hisa K: Factors affecting aseptic failure of fixation after primary Charnley total hip arthroplasty. Multivariate survival analysis. J Bone Joint Surg Am. 1997, 79: 1618-1627.
4.
go back to reference von Knoch M, Jewison DE, Sibonga JD, Turner RT, Morrey BF, Loer F, Berry DJ, Scully SP: Decrease in particle-induced osteolysis in obese (ob/ob) mice. Biomaterials. 2004, 25: 4675-4681. 10.1016/j.biomaterials.2004.02.069.CrossRef von Knoch M, Jewison DE, Sibonga JD, Turner RT, Morrey BF, Loer F, Berry DJ, Scully SP: Decrease in particle-induced osteolysis in obese (ob/ob) mice. Biomaterials. 2004, 25: 4675-4681. 10.1016/j.biomaterials.2004.02.069.CrossRef
5.
go back to reference Zhang C, Tang T, Ren W, Zhang X, Dai K: Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res. 2008, 57: 211-215. 10.1007/s00011-007-7040-3.CrossRef Zhang C, Tang T, Ren W, Zhang X, Dai K: Influence of mouse genetic background on wear particle-induced in vivo inflammatory osteolysis. Inflamm Res. 2008, 57: 211-215. 10.1007/s00011-007-7040-3.CrossRef
6.
go back to reference Nich C, Marchadier A, Sedel L, Petite H, Vidal C, Hamadouche M: Decrease in particle-induced osteolysis in ovariectomized mice. J Orthop Res. 2010, 28: 178-183. Nich C, Marchadier A, Sedel L, Petite H, Vidal C, Hamadouche M: Decrease in particle-induced osteolysis in ovariectomized mice. J Orthop Res. 2010, 28: 178-183.
7.
go back to reference Ishiguro N, Kojima T, Ito T, Saga S, Anma H, Kurokouchi K, Iwahori Y, Iwase T, Iwata H: Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res. 1997, 35: 399-406. 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A.CrossRef Ishiguro N, Kojima T, Ito T, Saga S, Anma H, Kurokouchi K, Iwahori Y, Iwase T, Iwata H: Macrophage activation and migration in interface tissue around loosening total hip arthroplasty components. J Biomed Mater Res. 1997, 35: 399-406. 10.1002/(SICI)1097-4636(19970605)35:3<399::AID-JBM14>3.0.CO;2-A.CrossRef
8.
go back to reference Green TR, Fisher J, Matthews JB, Stone MH, Ingham E: Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res. 2000, 53: 490-497. 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7.CrossRef Green TR, Fisher J, Matthews JB, Stone MH, Ingham E: Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res. 2000, 53: 490-497. 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7.CrossRef
9.
go back to reference Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y: IL-6, RANKL, TNFalpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15: 49-60. 10.1016/j.cytogfr.2003.10.005.CrossRef Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y: IL-6, RANKL, TNFalpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev. 2004, 15: 49-60. 10.1016/j.cytogfr.2003.10.005.CrossRef
10.
go back to reference Wronski TJ, Dann LM, Scott KS, Cintrón M: Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int. 1989, 45: 360-366. 10.1007/BF02556007.CrossRef Wronski TJ, Dann LM, Scott KS, Cintrón M: Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int. 1989, 45: 360-366. 10.1007/BF02556007.CrossRef
11.
go back to reference Passeri G, Girasole G, Jilka RL, Manolagas SC: Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 1993, 133: 822-828. 10.1210/en.133.2.822. Passeri G, Girasole G, Jilka RL, Manolagas SC: Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 1993, 133: 822-828. 10.1210/en.133.2.822.
12.
go back to reference Spelsberg TC, Subramaniam M, Riggs BL, Khosla S: The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol. 1999, 13: 819-828. 10.1210/me.13.6.819.CrossRef Spelsberg TC, Subramaniam M, Riggs BL, Khosla S: The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol. 1999, 13: 819-828. 10.1210/me.13.6.819.CrossRef
13.
go back to reference Müller R, van Campenhout H, van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Rüegsegger P: Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone. 1998, 23: 59-66. 10.1016/S8756-3282(98)00068-4.CrossRef Müller R, van Campenhout H, van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Rüegsegger P: Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone. 1998, 23: 59-66. 10.1016/S8756-3282(98)00068-4.CrossRef
14.
go back to reference van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs JW, Bijlsma JW: Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis. 1993, 52: 862-865. 10.1136/ard.52.12.862.CrossRef van den Brink HR, van Everdingen AA, van Wijk MJ, Jacobs JW, Bijlsma JW: Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis. 1993, 52: 862-865. 10.1136/ard.52.12.862.CrossRef
15.
go back to reference Hall GM, Daniels M, Huskisson EC, Spector TD: A randomized controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 1994, 53: 112-116. 10.1136/ard.53.2.112.CrossRef Hall GM, Daniels M, Huskisson EC, Spector TD: A randomized controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis. Ann Rheum Dis. 1994, 53: 112-116. 10.1136/ard.53.2.112.CrossRef
16.
go back to reference D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H: Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res Ther. 2003, 5: 202-209. 10.1186/ar788.CrossRef D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H: Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. Arthritis Res Ther. 2003, 5: 202-209. 10.1186/ar788.CrossRef
17.
go back to reference Yoneda T, Ishimaru N, Arakaki R, Kobayashi M, Izawa T, Moriyama K, Hayashi Y: Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology. 2004, 145: 2384-2391. 10.1210/en.2003-1536.CrossRef Yoneda T, Ishimaru N, Arakaki R, Kobayashi M, Izawa T, Moriyama K, Hayashi Y: Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. Endocrinology. 2004, 145: 2384-2391. 10.1210/en.2003-1536.CrossRef
18.
go back to reference Subramanian S, Tovey M, Afentoulis M, Krogstad A, Vandenbark AA, Offner H: Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol. 2005, 115: 162-172. 10.1016/j.clim.2005.01.006.CrossRef Subramanian S, Tovey M, Afentoulis M, Krogstad A, Vandenbark AA, Offner H: Ethinyl estradiol treats collagen-induced arthritis in DBA/1LacJ mice by inhibiting the production of TNF-alpha and IL-1beta. Clin Immunol. 2005, 115: 162-172. 10.1016/j.clim.2005.01.006.CrossRef
19.
go back to reference da Silva JA, Willoughby DA: The influence of sex in arthritis: is cartilage an overlooked factor?. J Rheumatol. 1994, 21: 791-796. da Silva JA, Willoughby DA: The influence of sex in arthritis: is cartilage an overlooked factor?. J Rheumatol. 1994, 21: 791-796.
20.
go back to reference Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R: Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem. 1996, 271: 28890-28897. 10.1074/jbc.271.46.28890.CrossRef Kimble RB, Srivastava S, Ross FP, Matayoshi A, Pacifici R: Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production. J Biol Chem. 1996, 271: 28890-28897. 10.1074/jbc.271.46.28890.CrossRef
21.
go back to reference Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, Mc Cabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309. 10.1038/46303.CrossRef Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, Mc Cabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999, 402: 304-309. 10.1038/46303.CrossRef
22.
go back to reference Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, Mc Cabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA. 2000, 97: 1566-1571. 10.1073/pnas.97.4.1566.CrossRef Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, Mc Cabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA. 2000, 97: 1566-1571. 10.1073/pnas.97.4.1566.CrossRef
23.
go back to reference Teitelbaum SL: Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab. 2000, 18: 344-349. 10.1007/s007740070007.CrossRef Teitelbaum SL: Osteoclasts, integrins, and osteoporosis. J Bone Miner Metab. 2000, 18: 344-349. 10.1007/s007740070007.CrossRef
24.
go back to reference Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S: Estrogen prevents bone loss via oestrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007, 130: 811-823. 10.1016/j.cell.2007.07.025.CrossRef Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S: Estrogen prevents bone loss via oestrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell. 2007, 130: 811-823. 10.1016/j.cell.2007.07.025.CrossRef
25.
go back to reference Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM: Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res. 2001, 16: 338-347. 10.1359/jbmr.2001.16.2.338.CrossRef Childs LM, Goater JJ, O'Keefe RJ, Schwarz EM: Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res. 2001, 16: 338-347. 10.1359/jbmr.2001.16.2.338.CrossRef
26.
go back to reference Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y: Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem. 2001, 276: 563-568.CrossRef Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y: Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem. 2001, 276: 563-568.CrossRef
27.
go back to reference Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R: Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 1995, 136: 3054-3061. 10.1210/en.136.7.3054. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R: Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology. 1995, 136: 3054-3061. 10.1210/en.136.7.3054.
28.
go back to reference Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R: Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which oestrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA. 2001, 98: 13960-13965. 10.1073/pnas.251534698.CrossRef Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R: Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which oestrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA. 2001, 98: 13960-13965. 10.1073/pnas.251534698.CrossRef
29.
go back to reference Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM: Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone. 2007, 40: 1276-1283. 10.1016/j.bone.2006.12.053.CrossRef Taki N, Tatro JM, Lowe R, Goldberg VM, Greenfield EM: Comparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic loosening. Bone. 2007, 40: 1276-1283. 10.1016/j.bone.2006.12.053.CrossRef
30.
go back to reference Lerner UH: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res. 2006, 85: 596-607. 10.1177/154405910608500704.CrossRef Lerner UH: Inflammation-induced bone remodeling in periodontal disease and the influence of post-menopausal osteoporosis. J Dent Res. 2006, 85: 596-607. 10.1177/154405910608500704.CrossRef
31.
go back to reference Lorenzo J: Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest. 2000, 106: 749-752. 10.1172/JCI11089.CrossRef Lorenzo J: Interactions between immune and bone cells: new insights with many remaining questions. J Clin Invest. 2000, 106: 749-752. 10.1172/JCI11089.CrossRef
32.
go back to reference Hernigou P, Intrator L, Bahrami T, Bensussan A, Farcet JP: Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res. 1999, 366: 147-154.CrossRef Hernigou P, Intrator L, Bahrami T, Bensussan A, Farcet JP: Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res. 1999, 366: 147-154.CrossRef
33.
go back to reference Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M: Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty. 2005, 20: 1049-1054. 10.1016/j.arth.2005.03.034.CrossRef Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M: Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty. 2005, 20: 1049-1054. 10.1016/j.arth.2005.03.034.CrossRef
34.
go back to reference Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R: Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000, 106: 1229-1237. 10.1172/JCI11066.CrossRef Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R: Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000, 106: 1229-1237. 10.1172/JCI11066.CrossRef
35.
go back to reference Weitzmann MN, Pacifici R: The role of T lymphocytes in bone metabolism. Immunol Rev. 2005, 208: 154-168. 10.1111/j.0105-2896.2005.00324.x.CrossRef Weitzmann MN, Pacifici R: The role of T lymphocytes in bone metabolism. Immunol Rev. 2005, 208: 154-168. 10.1111/j.0105-2896.2005.00324.x.CrossRef
36.
go back to reference Pacifici R: Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996, 11: 1043-1051.CrossRef Pacifici R: Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 1996, 11: 1043-1051.CrossRef
37.
go back to reference Sato T, Watanabe K, Masuhara M, Hada N, Hakeda Y: Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J Bone Miner Metab. 2007, 25: 19-27.CrossRef Sato T, Watanabe K, Masuhara M, Hada N, Hakeda Y: Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro. J Bone Miner Metab. 2007, 25: 19-27.CrossRef
38.
go back to reference Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX: Adaptive immune cells temper initial innate responses. Nat Med. 2007, 13: 1248-1252. 10.1038/nm1633.CrossRef Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX: Adaptive immune cells temper initial innate responses. Nat Med. 2007, 13: 1248-1252. 10.1038/nm1633.CrossRef
39.
go back to reference Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J: T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature. 2009, 460: 269-273. 10.1038/nature08100.CrossRef Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J: T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature. 2009, 460: 269-273. 10.1038/nature08100.CrossRef
40.
go back to reference Everts V, de Vries TJ, Helfrich MH: Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta. 2009, 1792: 757-765.CrossRef Everts V, de Vries TJ, Helfrich MH: Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. Biochim Biophys Acta. 2009, 1792: 757-765.CrossRef
41.
go back to reference de Souza Faloni AP, Schoenmaker T, Azari A, Katchburian E, Cerri PS, de Vries TJ, Everts V: Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int. 2011, 88: 63-74. 10.1007/s00223-010-9418-4.CrossRef de Souza Faloni AP, Schoenmaker T, Azari A, Katchburian E, Cerri PS, de Vries TJ, Everts V: Jaw and long bone marrows have a different osteoclastogenic potential. Calcif Tissue Int. 2011, 88: 63-74. 10.1007/s00223-010-9418-4.CrossRef
42.
go back to reference Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res. 2006, 21: 1399-1408. 10.1359/jbmr.060614.CrossRef Everts V, Korper W, Hoeben KA, Jansen ID, Bromme D, Cleutjens KB, Heeneman S, Peters C, Reinheckel T, Saftig P, Beertsen W: Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res. 2006, 21: 1399-1408. 10.1359/jbmr.060614.CrossRef
43.
go back to reference Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IM, Reinheckel T, Hayman AR, Cox TM, Saftig P, Beertsen W, Everts V: Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int. 2006, 79: 245-254. 10.1007/s00223-005-0289-z.CrossRef Perez-Amodio S, Jansen DC, Schoenmaker T, Vogels IM, Reinheckel T, Hayman AR, Cox TM, Saftig P, Beertsen W, Everts V: Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity. Calcif Tissue Int. 2006, 79: 245-254. 10.1007/s00223-005-0289-z.CrossRef
44.
go back to reference van de Bos T, Speijer D, Bank RA, Bromme D, Everts V: Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen. Bone. 2008, 43: 459-468. 10.1016/j.bone.2008.05.009.CrossRef van de Bos T, Speijer D, Bank RA, Bromme D, Everts V: Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen. Bone. 2008, 43: 459-468. 10.1016/j.bone.2008.05.009.CrossRef
45.
go back to reference Libouban H, Moreau MF, Baslé MF, Bataille R, Chappard D: Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone. 2003, 33: 283-292. 10.1016/S8756-3282(03)00196-0.CrossRef Libouban H, Moreau MF, Baslé MF, Bataille R, Chappard D: Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model. Bone. 2003, 33: 283-292. 10.1016/S8756-3282(03)00196-0.CrossRef
46.
go back to reference Takata S, Takao S, Yoshida S, Hayashi F, Yasui N: Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with pariétal thinning of skull. J Med Invest. 2008, 55: 297-302. 10.2152/jmi.55.297.CrossRef Takata S, Takao S, Yoshida S, Hayashi F, Yasui N: Therapeutic effects of one-year alendronate treatment in three cases of osteoporosis with pariétal thinning of skull. J Med Invest. 2008, 55: 297-302. 10.2152/jmi.55.297.CrossRef
Metadata
Title
Oestrogen deficiency modulates particle-induced osteolysis
Authors
Christophe Nich
Jean Langlois
Arnaud Marchadier
Catherine Vidal
Martine Cohen-Solal
Hervé Petite
Moussa Hamadouche
Publication date
01-06-2011
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2011
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3381

Other articles of this Issue 3/2011

Arthritis Research & Therapy 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.